80 likes | 234 Vues
This study explores the challenges and advancements in molecular imaging, specifically focusing on the dopaminergic system in both human and mouse models of Parkinson's disease. By leveraging first-pass PET imaging techniques with radioactively labeled molecules, the research aims to enhance sensitivity and specificity in visualizing biological and medically significant molecules present in minimal quantities. The investigation includes the role of integrin αVβ3 in angiogenesis and its implications for cellular adhesion and migration, which is vital for understanding tumor biology and treatment responses.
E N D
Dopamintransporter Myokardstoffwechsel * Mensch ** * Maus ** Normal Parkinson ** Enddiastole, * Endsystole Striatum Harder Drüsen der Maus
Herausforderungen Biologisch und medizinisch bedeutsame Moleküle liegen in minimalen Mengen vor (< 0.0001 Gramm pro Gramm Gewebe) Molekulare Bildgebung benötigt eine sehr hohe Empfindlichkeit Spezifität (keine Bindung an andere Moleküle) Aktuelles Verfahren in der Forschung und Klinik: Radioaktiv markierte Moleküle und Positronen-Emissions-Tomographie (PET) Molekulare Bildgebung
a-chain Ca2+ b-chain Ca2+ S S Ca2+ talin a-actinin Structure and function of the v3 integrin • heterodimeric membraneprotein • expressed on activated endothelialcells and some tumor cells (melanoma, glioblastoma) • mediates cellular adhesion and migration during angiogenesis and metastasis formation • binds to an arginine, glycine, aspartate sequence (RGD) of matrix proteins
Cyclic c(RGDfV) peptides bind specifically to the αVβ3, but not to related, RGD binding integrins Imaging the αVβ3 Integrin peptide integrin [nM] avb3 avb5 aIIbb3 c(RGDfV) 13 3,350 6,700 [I]Gluco-RGD 40 2,000 5,000 [F]Galacto-RGD 5 1,000 6,000
Imaging the αVβ3 Integrin 64Cu-DOTA-RGD Delayed images (22 hours post injection) 7 U87 A431 %ID/g 0 CT PET fusion projection Ferl et al. J Nucl Med 2009